{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:02:55Z","timestamp":1790816575929,"version":"4.1.0"},"reference-count":90,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>With the growing burden of ischemic stroke as a leading cause of mortality and long-term disability worldwide, the demand for innovative and effective therapeutic strategies has become increasingly urgent. Traditional interventions offer limited neurorestorative potential, prompting a shift toward regenerative approaches. Cell-based and exosome-based therapies have attracted significant interest due to their potential to regulate inflammation, safeguard neural tissue, and support recovery following ischemic injury. Mesenchymal stem cells (MSCs) exert neuroprotective effects through paracrine signaling, immune modulation, and intercellular mitochondrial transfer. In parallel, exosomes\u00a0\u2013\u00a0nano-sized extracellular vesicles derived from various cell types\u00a0\u2013\u00a0have emerged as a potent cell-free alternative, capable of delivering bioactive molecules such as microRNAs, proteins, and lipids to target cells, thereby mimicking many of the therapeutic functions of stem cells. Their favorable safety profile, ease of storage and handling, and potential for customization make them highly promising for clinical translation. This review aims to provide a comparative evaluation of cell-based and exosome-based therapies in the treatment of ischemic stroke. By analyzing key molecular mechanisms, therapeutic benefits, limitations, and translational challenges, we seek to highlight the relative strengths of each approach and offer insights that may guide future strategies for optimizing stroke recovery.<\/jats:p>","DOI":"10.1515\/revneuro-2025-0136","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T17:27:48Z","timestamp":1772299668000},"page":"365-377","source":"Crossref","is-referenced-by-count":1,"title":["From cells to vesicles: mechanisms and therapeutic promise of cell- and exosome-based interventions in ischemic stroke"],"prefix":"10.1515","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3724-2061","authenticated-orcid":false,"given":"Naeimeh","family":"Akbari-Gharalari","sequence":"first","affiliation":[{"name":"37555 Neurophysiology Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences , Urmia , 5715789400 , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1199-8553","authenticated-orcid":false,"given":"Amin","family":"Aghadoost","sequence":"additional","affiliation":[{"name":"37555 Student Research Committee, Urmia University of Medical Sciences , Urmia , 5756115198 , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4537-1925","authenticated-orcid":false,"given":"Ehsan","family":"Maroofi","sequence":"additional","affiliation":[{"name":"37555 Student Research Committee, Urmia University of Medical Sciences , Urmia , 5756115198 , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8613-4493","authenticated-orcid":false,"given":"Hamed","family":"Abkhiz","sequence":"additional","affiliation":[{"name":"37555 Student Research Committee, Urmia University of Medical Sciences , Urmia , 5756115198 , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8244-3951","authenticated-orcid":false,"given":"Mobin","family":"Hosseinzadeh","sequence":"additional","affiliation":[{"name":"37555 Student Research Committee, Urmia University of Medical Sciences , Urmia , 5756115198 , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8529-7306","authenticated-orcid":false,"given":"Roya","family":"Naderi","sequence":"additional","affiliation":[{"name":"Nephrology and Kidney Transplant Research Center, Clinical Research Institute, Urmia University of Medical Sciences , Urmia , 5756115198 , Iran"},{"name":"Department of Physiology , School of Medicine, Urmia University of Medical Sciences , Urmia , 5756115198 , Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"2026060415510902395_j_revneuro-2025-0136_ref_005","doi-asserted-by":"crossref","unstructured":"Akbari-Gharalari, N., Ghahremani-Nasab, M., Naderi, R., Chodari, L., and Nezhadshahmohammad, F. (2024a). The potential of exosomal biomarkers: revolutionizing Parkinson\u2019s disease: how do they influence pathogenesis, diagnosis, and therapeutic strategies? AIMS Neurosci. 11: 374\u2013397, https:\/\/doi.org\/10.3934\/neuroscience.2024023.","DOI":"10.3934\/Neuroscience.2024023"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_001","doi-asserted-by":"crossref","unstructured":"Akbari-Gharalari, N., Khodakarimi, S., Nezhadshahmohammad, F., Karimipour, M., Ebrahimi-Kalan, A., and Wu, J. (2024b). Exosomes in neuron-glia communication: a review on neurodegeneration. Bioimpacts 14: 30153, https:\/\/doi.org\/10.34172\/bi.2023.30153.","DOI":"10.34172\/bi.2023.30153"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_002","doi-asserted-by":"crossref","unstructured":"Akbari-Gharalari, N., Aliyari-Serej, Z., Ghahremani-Nasab, M., Zangbar, H.S., Yahyavi, Y., Nezhadshahmohammad, F., and Ebrahimi-Kalan, A. (2025a). Cerebrolysin-loaded platelet-rich plasma exosomes: restoring immune homeostasis through TNF-\u03b1\/IL-10 modulation and targeting apoptosis for spinal cord injury repair. J.\u00a0Spinal Cord Med. 5: 1\u201313, https:\/\/doi.org\/10.1080\/10790268.2025.2503053.","DOI":"10.1080\/10790268.2025.2503053"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_003","doi-asserted-by":"crossref","unstructured":"Akbari-Gharalari, N., Ebrahimi-Kalan, A., Aliyari-Serej, Z., Soltani Zangbar, H., Ghahremani-Nasab, M., yahyavi, Y., Ebrahimi, A., Aghaei, N., and Nezhadshahmohammad, F. (2025b). The role of autophagy in long-term effects of spinal cord injury: does exosome change the autophagy process and vice versa? Adv. Pharm. Bull. 0, https:\/\/doi.org\/10.34172\/apb.025.43284.","DOI":"10.34172\/apb.025.43284"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_004","doi-asserted-by":"crossref","unstructured":"Akbari-Gharalari, N., Ghahremani-Nasab, M., Naderi, R., Aliyari-Serej, Z., Karimipour, M., Shahabi, P., and Ebrahimi-Kalan, A. (2023). Improvement of spinal cord injury symptoms by targeting the Bax\/Bcl2 pathway and modulating TNF-\u03b1\/IL-10 using platelet-rich plasma exosomes loaded with dexamethasone. AIMS Neurosci. 10: 332\u2013353, https:\/\/doi.org\/10.3934\/neuroscience.2023026.","DOI":"10.3934\/Neuroscience.2023026"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_006","doi-asserted-by":"crossref","unstructured":"Alsbrook, D.L., Di Napoli, M., Bhatia, K., Biller, J., Andalib, S., Hinduja, A., Rodrigues, R., Rodriguez, M., Sabbagh, S.Y., Selim, M., et al.. (2023). Neuroinflammation in acute ischemic and hemorrhagic stroke. Curr. Neurol. Neurosci. Rep. 23: 407\u2013431, https:\/\/doi.org\/10.1007\/s11910-023-01282-2.","DOI":"10.1007\/s11910-023-01282-2"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_007","doi-asserted-by":"crossref","unstructured":"Bakreen, A., Juntunen, M., Dunlop, Y., Ugidos, I.F., Malm, T., Miettinen, S., and Jolkkonen, J. (2021). Additive behavioral improvement after combined cell therapy and rehabilitation despite long-term microglia presence in stroke rats. Int. J.\u00a0Mol. Sci. 22: 1512, https:\/\/doi.org\/10.3390\/ijms22041512.","DOI":"10.3390\/ijms22041512"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_008","unstructured":"Bejleri, J. (2024). microRNAs as novel diagnostic targets in ischaemic stroke, Doctor of Medicine. Thesis. Royal College of Surgeons in Ireland."},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_009","doi-asserted-by":"crossref","unstructured":"Bhattacharya, A., Ashouri, R., Fangman, M., Mazur, A., Garett, T., and Dor\u00e9, S. (2021). Soluble receptors affecting stroke outcomes: potential biomarkers and therapeutic tools. Int. J.\u00a0Mol. Sci. 22: 1108, https:\/\/doi.org\/10.3390\/ijms22031108.","DOI":"10.3390\/ijms22031108"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_010","doi-asserted-by":"crossref","unstructured":"Bischoff, J.P., Schulz, A., and Morrison, H. (2022). The role of exosomes in intercellular and inter\u2010organ communication of the peripheral nervous system. FEBS Lett. 596: 655\u2013664, https:\/\/doi.org\/10.1002\/1873-3468.14274.","DOI":"10.1002\/1873-3468.14274"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_011","doi-asserted-by":"crossref","unstructured":"Braicu, C., Mure\u015fanu, F.D., Isachesku, E., Bornstein, N., Filipovi\u0107, S.R., Strilciuc, S., and Pana, A. (2025). Role of miR-181 family members in stroke: insights into mechanisms and therapeutic potential. Int. J.\u00a0Mol. Sci. 26: 440, https:\/\/doi.org\/10.3390\/ijms26020440.","DOI":"10.3390\/ijms26020440"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_012","doi-asserted-by":"crossref","unstructured":"Carvalho Ferraz, L., Pereira, P., and Ferreira, J.V. (2025). Molecular mechanisms of extracellular vesicle biogenesis and their impact on the design of custom EVs. Adv. Healthc. Mater., n\/a: 2501349, https:\/\/doi.org\/10.1002\/adhm.202501349.","DOI":"10.1002\/adhm.202501349"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_013","doi-asserted-by":"crossref","unstructured":"Dehghani, L., Khojasteh, A., Soleimani, M., Oraee-Yazdani, S., Keshel, S.H., Saadatnia, M., Saboori, M., Zali, A., Hashemi, S.M., and Soleimani, R. (2022). Safety of intraparenchymal injection of Allogenic Placenta mesenchymal stem cells derived exosome in patients undergoing decompressive craniectomy following malignant middle cerebral artery infarct, A pilot randomized clinical trial. Int. J.\u00a0Prev. Med. 13: 7, https:\/\/doi.org\/10.4103\/ijpvm.ijpvm_441_21.","DOI":"10.4103\/ijpvm.ijpvm_441_21"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_014","doi-asserted-by":"crossref","unstructured":"Dilsiz, N. (2024). A comprehensive review on recent advances in exosome isolation and characterization: toward clinical applications. Transl. Oncol. 50: 102121, https:\/\/doi.org\/10.1016\/j.tranon.2024.102121.","DOI":"10.1016\/j.tranon.2024.102121"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_015","doi-asserted-by":"crossref","unstructured":"Donders, R., Vanheusden, M., Bogie, J.F., Ravanidis, S., Thewissen, K., Stinissen, P., Gyselaers, W., Hendriks, J.J., and Hellings, N. (2015). Human Wharton\u2019s jelly-derived stem cells display immunomodulatory properties and transiently improve rat experimental autoimmune encephalomyelitis. Cell Transplant. 24: 2077\u20132098, https:\/\/doi.org\/10.3727\/096368914x685104.","DOI":"10.3727\/096368914X685104"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_016","doi-asserted-by":"crossref","unstructured":"Duan, S., Wang, F., Cao, J., and Wang, C. (2020). Exosomes derived from MicroRNA-146a-5p-enriched bone marrow mesenchymal stem cells alleviate intracerebral hemorrhage by inhibiting neuronal apoptosis and microglial M1 polarization. Drug Des. Devel. Ther.: 3143\u20133158, https:\/\/doi.org\/10.2147\/dddt.s255828.","DOI":"10.2147\/DDDT.S255828"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_017","doi-asserted-by":"crossref","unstructured":"Ejma, M., Madetko, N., Brzecka, A., Alster, P., Budrewicz, S., Koszewicz, M., Misiuk-Hoj\u0142o, M., Tomilova, I.K., Somasundaram, S.G., and Kirkland, C.E. (2022). The role of stem cells in the therapy of stroke. Curr. Neuropharmacol. 20: 630\u2013647, https:\/\/doi.org\/10.2174\/1570159x19666210806163352.","DOI":"10.2174\/1570159X19666210806163352"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_018","doi-asserted-by":"crossref","unstructured":"El Andaloussi, S., M\u00e4ger, I., Breakefield, X.O., and Wood, M.J. (2013). Extracellular vesicles: biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov. 12: 347\u2013357, https:\/\/doi.org\/10.1038\/nrd3978.","DOI":"10.1038\/nrd3978"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_019","doi-asserted-by":"crossref","unstructured":"Endres, M., Moro, M.A., Nolte, C.H., Dames, C., Buckwalter, M.S., and Meisel, A. (2022). Immune pathways in etiology, acute phase, and chronic sequelae of ischemic stroke. Circ. Res. 130: 1167\u20131186, https:\/\/doi.org\/10.1161\/circresaha.121.319994.","DOI":"10.1161\/CIRCRESAHA.121.319994"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_020","doi-asserted-by":"crossref","unstructured":"Essig, F., Kollikowski, A.M., Pham, M., Solymosi, L., Stoll, G., Haeusler, K.G., Kraft, P., and Schuhmann, M.K. (2020). Immunohistological analysis of neutrophils and neutrophil extracellular traps in human thrombemboli causing acute ischemic stroke. Int. J.\u00a0Mol. Sci. 21: 7387, https:\/\/doi.org\/10.3390\/ijms21197387.","DOI":"10.3390\/ijms21197387"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_021","doi-asserted-by":"crossref","unstructured":"Feigin, V.L., Brainin, M., Norrving, B., Martins, S.O., Pandian, J., Lindsay, P., F Grupper, M., and Rautalin, I. (2025). World stroke organization: global stroke fact sheet 2025. Int. J.\u00a0Stroke 20: 132\u2013144, https:\/\/doi.org\/10.1177\/17474930241308142.","DOI":"10.1177\/17474930241308142"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_022","doi-asserted-by":"crossref","unstructured":"Fukuda, H., Takahashi, J., Watanabe, K., Hayashi, H., Morizane, A., Koyanagi, M., Sasai, Y., and Hashimoto, N. (2006). Fluorescence-activated cell sorting\u2013based purification of embryonic stem cell\u2013derived neural precursors averts tumor formation after transplantation. Stem Cells 24: 763\u2013771, https:\/\/doi.org\/10.1634\/stemcells.2005-0137.","DOI":"10.1634\/stemcells.2005-0137"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_023","doi-asserted-by":"crossref","unstructured":"Guay, C. and Regazzi, R. (2017). Exosomes as new players in metabolic organ cross\u2010talk. Diabetes Obes. Metab. 19: 137\u2013146, https:\/\/doi.org\/10.1111\/dom.13027.","DOI":"10.1111\/dom.13027"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_024","doi-asserted-by":"crossref","unstructured":"Guo, L., Huang, Z., Huang, L., Liang, J., Wang, P., Zhao, L., and Shi, Y. (2021a). Surface-modified engineered exosomes attenuated cerebral ischemia\/reperfusion injury by targeting the delivery of quercetin towards impaired neurons. J.\u00a0Nanobiotechnol. 19: 141, https:\/\/doi.org\/10.1186\/s12951-021-00879-4.","DOI":"10.1186\/s12951-021-00879-4"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_025","doi-asserted-by":"crossref","unstructured":"Guo, L., Pan, J., Li, F., Zhao, L., and Shi, Y. (2021b). A novel brain targeted plasma exosomes enhance the neuroprotective efficacy of edaravone in ischemic stroke. IET Nanobiotechnol. 15: 107\u2013116, https:\/\/doi.org\/10.1049\/nbt2.12003.","DOI":"10.1049\/nbt2.12003"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_026","doi-asserted-by":"crossref","unstructured":"Guo, Y., Peng, Y., Zeng, H., and Chen, G. (2021c). Progress in mesenchymal stem cell therapy for ischemic stroke. Stem Cells Int. 2021: 9923566, https:\/\/doi.org\/10.1155\/2021\/9923566.","DOI":"10.1155\/2021\/9923566"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_027","doi-asserted-by":"crossref","unstructured":"Gurunathan, S., Kang, M.-H., and Kim, J.-H. (2021). A comprehensive review on factors influences biogenesis, functions, therapeutic and clinical implications of exosomes. Int. J.\u00a0Nanomed. 16: 1281\u20131312, https:\/\/doi.org\/10.2147\/ijn.s291956.","DOI":"10.2147\/IJN.S291956"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_028","doi-asserted-by":"crossref","unstructured":"Harshfield, E.L., Georgakis, M.K., Malik, R., Dichgans, M., and Markus, H.S. (2021). Modifiable lifestyle factors and risk of stroke: a Mendelian randomization analysis. Stroke 52: 931\u2013936, https:\/\/doi.org\/10.1161\/strokeaha.120.031710.","DOI":"10.1161\/STROKEAHA.120.031710"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_029","doi-asserted-by":"crossref","unstructured":"Haworth, R. and Sharpe, M. (2021). Accept or reject: the role of immune tolerance in the development of stem cell therapies and possible future approaches. Toxicol. Pathol. 49: 1308\u20131316, https:\/\/doi.org\/10.1177\/0192623320918241.","DOI":"10.1177\/0192623320918241"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_030","doi-asserted-by":"crossref","unstructured":"Hirsch, Y., Geraghty, J.R., Reiter, C.R., Katz, E.A., Little, C.F., Tobin, M.K., and Testai, F.D. (2023). Unpacking the role of extracellular vesicles in ischemic and hemorrhagic stroke: pathophysiology and therapeutic implications. Transl. Stroke Res. 14: 146\u2013159, https:\/\/doi.org\/10.1007\/s12975-022-01027-2.","DOI":"10.1007\/s12975-022-01027-2"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_031","doi-asserted-by":"crossref","unstructured":"Jablonska, A., Kozlowska, H., Markiewicz, I., Domanska-Janik, K., and Lukomska, B. (2010). Transplantation of neural stem cells derived from human cord blood to the brain of adult and neonatal rats. Acta Neurobiol. Exp. 70: 337\u2013350, https:\/\/doi.org\/10.55782\/ane-2010-1806.","DOI":"10.55782\/ane-2010-1806"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_032","doi-asserted-by":"crossref","unstructured":"Jiang, L., Chen, W., Ye, J., and Wang, Y. (2022). Potential role of exosomes in ischemic stroke treatment. Biomolecules 12: 115, https:\/\/doi.org\/10.3390\/biom12010115.","DOI":"10.3390\/biom12010115"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_033","doi-asserted-by":"crossref","unstructured":"Jiang, S., Hu, L., Zhou, H., Wu, J., Zhou, J., Yu, X., and Chen, G. (2024). Novel therapeutic mechanisms and strategies for intracerebral hemorrhage: focusing on exosomes. Int. J.\u00a0Nanomed.: 8987\u20139007, https:\/\/doi.org\/10.2147\/ijn.s473611.","DOI":"10.2147\/IJN.S473611"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_034","doi-asserted-by":"crossref","unstructured":"Jiang, Y., Lin, L., Liu, N., Wang, Q., Yuan, J., Li, Y., Chung, K.K., Guo, S., Yu, Z., and Wang, X. (2020). FGF21 protects against aggravated blood-brain barrier disruption after ischemic focal stroke in diabetic db\/db male mice via cerebrovascular PPAR\u03b3 activation. Int. J.\u00a0Mol. Sci. 21: 824, https:\/\/doi.org\/10.3390\/ijms21030824.","DOI":"10.3390\/ijms21030824"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_035","doi-asserted-by":"crossref","unstructured":"Jolugbo, P. and Ariens, R.A. (2021). Thrombus composition and efficacy of thrombolysis and thrombectomy in acute ischemic stroke. Stroke 52: 1131\u20131142, https:\/\/doi.org\/10.1161\/strokeaha.120.032810.","DOI":"10.1161\/STROKEAHA.120.032810"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_036","doi-asserted-by":"crossref","unstructured":"Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., C\u00e9cillion, M., Mar\u00e9chal, E., et al.. (1996). Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383: 707\u2013710, https:\/\/doi.org\/10.1038\/383707a0.","DOI":"10.1038\/383707a0"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_037","doi-asserted-by":"crossref","unstructured":"Jurcau, A. and Ardelean, A.I. (2022). Oxidative stress in ischemia\/reperfusion injuries following acute ischemic stroke. Biomedicines 10: 574, https:\/\/doi.org\/10.3390\/biomedicines10030574.","DOI":"10.3390\/biomedicines10030574"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_038","doi-asserted-by":"crossref","unstructured":"Kaiser, E.E., Waters, E.S., Yang, X., Fagan, M.M., Scheulin, K.M., Sneed, S.E., Cheek, S.R., Jeon, J.H., Shin, S.K., Kinder, H.A., et al.. (2022). Tanshinone IIA-loaded nanoparticle and neural stem cell therapy enhances recovery in a pig ischemic stroke model. Stem Cells Transl. Med. 11: 1061\u20131071, https:\/\/doi.org\/10.1093\/stcltm\/szac062.","DOI":"10.1093\/stcltm\/szac062"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_039","doi-asserted-by":"crossref","unstructured":"Kaur, H., Sarmah, D., Veeresh, P., Datta, A., Kalia, K., Borah, A., Yavagal, D.R., and Bhattacharya, P. (2021). Endovascular stem cell therapy post stroke rescues neurons from endoplasmic reticulum stress-induced apoptosis by modulating brain-derived neurotrophic factor\/tropomyosin receptor kinase B signaling. ACS Chem Neurosci 12: 3745\u20133759, https:\/\/doi.org\/10.1021\/acschemneuro.1c00506.","DOI":"10.1021\/acschemneuro.1c00506"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_040","doi-asserted-by":"crossref","unstructured":"Khan, H., Pan, J.-J., Li, Y., Zhang, Z., and Yang, G.-Y. (2021). Native and bioengineered exosomes for ischemic stroke therapy [review]. Front. Cell Dev. Biol. 9.","DOI":"10.3389\/fcell.2021.619565"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_041","doi-asserted-by":"crossref","unstructured":"Krylova, S.V. and Feng, D. (2023). The machinery of exosomes: biogenesis, release, and uptake. Int. J.\u00a0Mol. Sci. 24: 1337, https:\/\/doi.org\/10.3390\/ijms24021337.","DOI":"10.3390\/ijms24021337"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_042","doi-asserted-by":"crossref","unstructured":"Liu, C., Yang, T.H., Li, H.D., Li, G.Z., Liang, J., and Wang, P. (2023). Exosomes from bone marrow mesenchymal stem cells are a potential treatment for ischemic stroke. Neural. Regen Res. 18: 2246\u20132251, https:\/\/doi.org\/10.4103\/1673-5374.369114.","DOI":"10.4103\/1673-5374.369114"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_043","doi-asserted-by":"crossref","unstructured":"Larson, A., Natera-Rodriguez, D.E., Crane, A., Larocca, D., Low, W.C., Grande, A.W., and Lee, J. (2024). Emerging roles of exosomes in stroke therapy. Int. J.\u00a0Mol. Sci. 25: 6507, https:\/\/doi.org\/10.3390\/ijms25126507.","DOI":"10.3390\/ijms25126507"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_044","doi-asserted-by":"crossref","unstructured":"Leung, S.W., Lai, J.H., Wu, J.C.-C., Tsai, Y.-R., Chen, Y.-H., Kang, S.-J., Chiang, Y.-H., Chang, C.-F., and Chen, K.-Y. (2020). Neuroprotective effects of emodin against ischemia\/reperfusion injury through activating ERK-1\/2 signaling pathway. Int. J.\u00a0Mol. Sci. 21: 2899, https:\/\/doi.org\/10.3390\/ijms21082899.","DOI":"10.3390\/ijms21082899"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_045","doi-asserted-by":"crossref","unstructured":"Mani, K.K., El-Hakim, Y., Branyan, T.E., Samiya, N., Pandey, S., Grimaldo, M.T., Habbal, A., Wertz, A., and Sohrabji, F. (2023). Intestinal epithelial stem cell transplants as a novel therapy for cerebrovascular stroke. Brain Behav. Immun. 107: 345\u2013360, https:\/\/doi.org\/10.1016\/j.bbi.2022.10.015.","DOI":"10.1016\/j.bbi.2022.10.015"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_046","doi-asserted-by":"crossref","unstructured":"Meng, S., Bai, M., Ma, C., Han, B., Duan, M., Zhang, L., Guo, J., Shi, C., Li, K., and He, M. (2025). Mitochondrial transfer as a novel therapeutic approach in ischemic stroke treatment: current challenges and future perspectives. Neuroprotection 3: 253\u2013265, https:\/\/doi.org\/10.1002\/nep3.70004.","DOI":"10.1002\/nep3.70004"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_047","doi-asserted-by":"crossref","unstructured":"Mondal, J., Pillarisetti, S., Junnuthula, V., Saha, M., Hwang, S.R., Park, I.-k., and Lee, Y.-k. (2023). Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications. J.\u00a0Control Release 353: 1127\u20131149, https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.027.","DOI":"10.1016\/j.jconrel.2022.12.027"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_048","doi-asserted-by":"crossref","unstructured":"Muir, K.W., Bulters, D., Willmot, M., Sprigg, N., Dixit, A., Ward, N., Tyrrell, P., Majid, A., Dunn, L., Bath, P., et al.. (2020). Intracerebral implantation of human neural stem cells and motor recovery after stroke: Multicentre prospective single-arm study (PISCES-2). J.\u00a0Neurol. Neurosurg. Psychiatry. 91: 396\u2013401, https:\/\/doi.org\/10.1136\/jnnp-2019-322515.","DOI":"10.1136\/jnnp-2019-322515"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_049","doi-asserted-by":"crossref","unstructured":"Nistor-Cseppent\u00f6, D.C., Jurc\u0103u, M.C., Jurc\u0103u, A., Andronie-Cioar\u0103, F.L., and Marcu, F. (2022). Stem cell-and cell-based therapies for ischemic stroke. Bioengineering 9: 717.","DOI":"10.3390\/bioengineering9110717"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_050","doi-asserted-by":"crossref","unstructured":"Nucci, M.P., Oliveira, F.A., Ferreira, J.M., Pinto, Y.O., Alves, A.H., Mamani, J.B., Nucci, L.P., Valle, N.M.E., and Gamarra, L.F. (2022). Effect of cell therapy and exercise training in a stroke model, considering the cell track by molecular image and behavioral analysis. Cells 11: 485, https:\/\/doi.org\/10.3390\/cells11030485.","DOI":"10.3390\/cells11030485"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_051","doi-asserted-by":"crossref","unstructured":"Oeller, M., Laner-Plamberger, S., Hochmann, S., Ketterl, N., Feichtner, M., Brachtl, G., Hochreiter, A., Scharler, C., Bieler, L., Romanelli, P., et al.. (2018). Selection of tissue factor-deficient cell transplants as a novel strategy for improving hemocompatibility of human bone marrow stromal cells. Theranostics 8: 1421, https:\/\/doi.org\/10.7150\/thno.21906.","DOI":"10.7150\/thno.21906"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_052","doi-asserted-by":"crossref","unstructured":"Omrani, M., Beyrampour-Basmenj, H., Jahanban-Esfahlan, R., Talebi, M., Raeisi, M., Serej, Z.A., Akbar-Gharalari, N., Khodakarimi, S., Wu, J., and Ebrahimi-kalan, A. (2023). Global trend in exosome isolation and application: an update concept in management of diseases. Mol. Cell. Biochem. 479: 679\u2013691, https:\/\/doi.org\/10.1007\/s11010-023-04756-6.","DOI":"10.1007\/s11010-023-04756-6"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_053","doi-asserted-by":"crossref","unstructured":"Omrani, M.H., Khodakarimi, S., Beyrampour-Basmenj, H., Talebi, M., Akbari-Gharalari, N., Karimi, A., Aliyari-Serej, Z., Eyvazi, M., Mehdipour, A., and Ebrahimi-Kalan, A. (2025). Exploring the therapeutic potential of Cerebrolysin-loaded exosomes in multiple sclerosis; an experimental study on neuroprotection and immune modulation. Immunopathol. Persa. 11: e41735, https:\/\/doi.org\/10.34172\/ipp.2025.41735.","DOI":"10.34172\/ipp.2025.41735"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_054","doi-asserted-by":"crossref","unstructured":"Otero-Ortega, L., Laso-Garc\u00eda, F., Frutos, M.C.G.-d., Diekhorst, L., Mart\u00ednez-Arroyo, A., Alonso-L\u00f3pez, E., Garc\u00eda-Bermejo, M.L., Rodr\u00edguez-Serrano, M., Arr\u00fae-Gonzalo, M., D\u00edez-Tejedor, E., et al.. (2020). Low dose of extracellular vesicles identified that promote recovery after ischemic stroke. Stem Cell Res. Ther. 11: 70, https:\/\/doi.org\/10.1186\/s13287-020-01601-1.","DOI":"10.1186\/s13287-020-01601-1"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_055","doi-asserted-by":"crossref","unstructured":"Palakurthi, S.S., Shah, B., Kapre, S., Charbe, N., Immanuel, S., Pasham, S., Thalla, M., Jain, A., and Palakurthi, S. (2024). A comprehensive review of challenges and advances in exosome-based drug delivery systems. Nanoscale Adv. 6: 5803\u20135826, https:\/\/doi.org\/10.1039\/d4na00501e.","DOI":"10.1039\/D4NA00501E"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_056","doi-asserted-by":"crossref","unstructured":"Panos, L.D., Bargiotas, P., Arnold, M., Hadjigeorgiou, G., and Panos, G.D. (2024). Revolutionizing stroke recovery: unveiling the promise of stem cell therapy. Drug Des. Devel. Ther. 18: 991\u20131006, https:\/\/doi.org\/10.2147\/dddt.s460998.","DOI":"10.2147\/DDDT.S460998"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_057","doi-asserted-by":"crossref","unstructured":"Pathipati, P., Lecuyer, M., Faustino, J., Strivelli, J., Phinney, D.G., and Vexler, Z.S. (2021). Mesenchymal stem cell (MSC)-derived extracellular vesicles protect from neonatal stroke by interacting with microglial cells. Neurotherapeutics 18: 1939\u20131952, https:\/\/doi.org\/10.1007\/s13311-021-01076-9.","DOI":"10.1007\/s13311-021-01076-9"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_058","doi-asserted-by":"crossref","unstructured":"Qiu, L., Cai, Y., Geng, Y., Yao, X., Wang, L., Cao, H., Zhang, X., Wu, Q., Kong, D., Ding, D., et al.. (2022). Mesenchymal stem cell-derived extracellular vesicles attenuate tPA-induced blood-brain barrier disruption in murine ischemic stroke models. Acta Biomater. 154: 424\u2013442, https:\/\/doi.org\/10.1016\/j.actbio.2022.10.022.","DOI":"10.1016\/j.actbio.2022.10.022"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_059","doi-asserted-by":"crossref","unstructured":"Qiu, Y.-m., Zhang, C.-l., Chen, A.-q., Wang, H.-l., Zhou, Y.-f., Li, Y.-n., and Hu, B. (2021). Immune cells in the BBB disruption after acute ischemic stroke: targets for immune therapy? Front Immunol. 12: 678744, https:\/\/doi.org\/10.3389\/fimmu.2021.678744.","DOI":"10.3389\/fimmu.2021.678744"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_060","doi-asserted-by":"crossref","unstructured":"Roshan-Milani, S., Sattari, P., Ghaderi-Pakdel, F., and Naderi, R. (2022). miR-23b\/TAB3\/NF-\u03baB\/p53 axis is involved in hippocampus injury induced by cerebral ischemia-reperfusion in rats: the protective effect of chlorogenic acid. Biofactors 48: 908\u2013917.","DOI":"10.1002\/biof.1830"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_061","doi-asserted-by":"crossref","unstructured":"Rubattu, S., Giliberti, R., and Volpe, M. (2000). Etiology and pathophysiology of stroke as a complex trait. Am. J.\u00a0Hypertens. 13: 1139\u20131148, https:\/\/doi.org\/10.1016\/s0895-7061(00)01249-8.","DOI":"10.1016\/S0895-7061(00)01249-8"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_062","doi-asserted-by":"crossref","unstructured":"Salimi, R., Naderi, R., and Shirpoor, A. (2023). Involvement of miR-27a\/smurf1\/TNF-\u03b1 and mitochondrial apoptotic pathway in apoptosis induced by cerebral ischemia-reperfusion injury in rats: the protective effect of chlorogenic acid. Neurosci. Lett. 817: 137529, https:\/\/doi.org\/10.1016\/j.neulet.2023.137529.","DOI":"10.1016\/j.neulet.2023.137529"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_063","doi-asserted-by":"crossref","unstructured":"Saniei, H. and Naderi, R. (2025). The effect of N-acetylcysteine on apoptosis and NGF-Akt\/Bad pathway in the hippocampus tissue of cerebral ischemia-reperfusion in male rats. Metab. Brain Dis. 40: 217, https:\/\/doi.org\/10.1007\/s11011-025-01641-7.","DOI":"10.1007\/s11011-025-01641-7"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_064","doi-asserted-by":"crossref","unstructured":"Sarmah, D., Datta, A., Rana, N., Suthar, P., Gupta, V., Kaur, H., Ghosh, B., Levoux, J., Rodriguez, A.M., Yavagal, D.R., et al.. (2024). SIRT-1\/RHOT-1\/PGC-1\u03b1 loop modulates mitochondrial biogenesis and transfer to offer resilience following endovascular stem cell therapy in ischemic stroke. Free Radic Biol Med 225: 255\u2013274, https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.09.022.","DOI":"10.1016\/j.freeradbiomed.2024.09.022"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_065","doi-asserted-by":"crossref","unstructured":"Sheikh, A.M., Hossain, S., and Tabassum, S. (2024). Advances in stem cell therapy for stroke: mechanisms, challenges, and future directions. Regen Med. Rep. 1: 76\u201392, https:\/\/doi.org\/10.4103\/rmr.regenmed-d-23-00002.","DOI":"10.4103\/RMR.REGENMED-D-23-00002"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_066","doi-asserted-by":"crossref","unstructured":"Shen, H., Yao, X., Li, H., Li, X., Zhang, T., Sun, Q., Ji, C., and Chen, G. (2018). Role of exosomes derived from miR-133b modified MSCs in an experimental rat model of intracerebral hemorrhage. J.\u00a0Mol. Neurosci. 64: 421\u2013430, https:\/\/doi.org\/10.1007\/s12031-018-1041-2.","DOI":"10.1007\/s12031-018-1041-2"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_067","doi-asserted-by":"crossref","unstructured":"Si, Y., Liu, F., Wang, D., Fang, C., Tang, X., Guo, B., Shi, Z., Dong, Z., Guo, D., Yue, J., et al.. (2021). Exosomal transfer of miR-185 is controlled by hnRNPA2B1 and impairs Re-endothelialization after vascular injury. Front. Cell Dev. Biol. 9, https:\/\/doi.org\/10.3389\/fcell.2021.619444.","DOI":"10.3389\/fcell.2021.619444"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_068","doi-asserted-by":"crossref","unstructured":"Song, J., Zhou, D., Cui, L., Wu, C., Jia, L., Wang, M., Li, J., Ya, J., Ji, X., and Meng, R. (2024). Advancing stroke therapy: innovative approaches with stem cell-derived extracellular vesicles. Cell Commun. Signal 22: 369, https:\/\/doi.org\/10.1186\/s12964-024-01752-1.","DOI":"10.1186\/s12964-024-01752-1"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_069","doi-asserted-by":"crossref","unstructured":"Sun, L., Xu, R., Sun, X., Duan, Y., Han, Y., Zhao, Y., Qian, H., Zhu, W., and Xu, W. (2016). Safety evaluation of exosomes derived from human umbilical cord mesenchymal stromal cell. Cytotherapy 18: 413\u2013422, https:\/\/doi.org\/10.1016\/j.jcyt.2015.11.018.","DOI":"10.1016\/j.jcyt.2015.11.018"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_070","doi-asserted-by":"crossref","unstructured":"Tanaka, E., Ogawa, Y., Mukai, T., Sato, Y., Hamazaki, T., Nagamura-Inoue, T., Harada-Shiba, M., Shintaku, H., and Tsuji, M. (2018). Dose-dependent effect of intravenous administration of human umbilical cord-derived mesenchymal stem cells in neonatal stroke mice. Front Neurol. 9: 133, https:\/\/doi.org\/10.3389\/fneur.2018.00133.","DOI":"10.3389\/fneur.2018.00133"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_071","doi-asserted-by":"crossref","unstructured":"Teow, S.-Y., Nordin, A.C., Ali, S.A., and Khoo, A.S.-B. (2016). Exosomes in human immunodeficiency virus type I pathogenesis: threat or opportunity? Adv. Virol. 2016: 9852494, https:\/\/doi.org\/10.1155\/2016\/9852494.","DOI":"10.1155\/2016\/9852494"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_072","doi-asserted-by":"crossref","unstructured":"Tian, J., Han, Z., Song, D., Peng, Y., Xiong, M., Chen, Z., Duan, S., and Zhang, L. (2023). Engineered exosome for drug delivery: recent development and clinical applications. Int. J.\u00a0Nanomed.: 7923\u20137940, https:\/\/doi.org\/10.2147\/ijn.s444582.","DOI":"10.2147\/IJN.S444582"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_073","doi-asserted-by":"crossref","unstructured":"Walter, K. (2022). What is acute ischemic stroke? Jama 327: 885, https:\/\/doi.org\/10.1001\/jama.2022.1420.","DOI":"10.1001\/jama.2022.1420"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_074","doi-asserted-by":"crossref","unstructured":"Wang, Y., Fang, J., Liu, B., Shao, C., and Shi, Y. (2022). Reciprocal regulation of mesenchymal stem cells and immune responses. Cell Stem Cell 29: 1515\u20131530, https:\/\/doi.org\/10.1016\/j.stem.2022.10.001.","DOI":"10.1016\/j.stem.2022.10.001"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_075","doi-asserted-by":"crossref","unstructured":"Wang, W., Sun, H., Duan, H., Sheng, G., Tian, N., Liu, D., and Sun, Z. (2024a). Isolation and usage of exosomes in central nervous system diseases. CNS Neurosci. Ther. 30: e14677, https:\/\/doi.org\/10.1111\/cns.14677.","DOI":"10.1111\/cns.14677"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_076","doi-asserted-by":"crossref","unstructured":"Wang, Z., Zhao, Y., Hou, Y., Tang, G., Zhang, R., Yang, Y., Yan, X., and Fan, K. (2024b). A thrombin\u2010activated peptide\u2010templated nanozyme for remedying ischemic stroke via thrombolytic and neuroprotective actions. Adv. Mater. 36: 2210144, https:\/\/doi.org\/10.1002\/adma.202210144.","DOI":"10.1002\/adma.202210144"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_077","doi-asserted-by":"crossref","unstructured":"Waqas, M.Y., Javid, M.A., Nazir, M.M., Niaz, N., Nisar, M.F., Manzoor, Z., Bhatti, S.A., Hameed, S., and Khaliq, M.H. (2022). Extracellular vesicles and exosome: insight from physiological regulatory perspectives. J.\u00a0Physiol. Biochem. 78: 573\u2013580, https:\/\/doi.org\/10.1007\/s13105-022-00877-6.","DOI":"10.1007\/s13105-022-00877-6"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_078","doi-asserted-by":"crossref","unstructured":"Waseem, A., Saudamini, Haque, R., Janowski, M., and Raza, S.S. (2023). Mesenchymal stem cell-derived exosomes: shaping the next era of stroke treatment. Neuroprotection 1: 99\u2013116, https:\/\/doi.org\/10.1002\/nep3.30.","DOI":"10.1002\/nep3.30"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_079","doi-asserted-by":"crossref","unstructured":"Wu, F., Liu, Z., Zhou, L., Ye, D., Zhu, Y., Huang, K., Weng, Y., Xiong, X., Zhan, R., and Shen, J. (2022). Systemic immune responses after ischemic stroke: from the center to the periphery. Front Immunol. 13: 911661, https:\/\/doi.org\/10.3389\/fimmu.2022.911661.","DOI":"10.3389\/fimmu.2022.911661"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_080","doi-asserted-by":"crossref","unstructured":"Xie, S., Zhang, Q., and Jiang, L. (2022). Current knowledge on exosome biogenesis, cargo-sorting mechanism and therapeutic implications. Membranes 12: 498, https:\/\/doi.org\/10.3390\/membranes12050498.","DOI":"10.3390\/membranes12050498"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_081","doi-asserted-by":"crossref","unstructured":"Xin, M., Hao, Y., Huang, G., Wang, X., Liang, Z., Miao, J., Ma, D., and Feng, J. (2020). The efficacy and safety of salvianolic acids on acute cerebral infarction treatment: a protocol for systematic review and meta analysis. Medicine 99: e20059, https:\/\/doi.org\/10.1097\/md.0000000000020059.","DOI":"10.1097\/MD.0000000000020059"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_082","doi-asserted-by":"crossref","unstructured":"Xin, H., Li, Y., Cui, Y., Yang, J.J., Zhang, Z.G., and Chopp, M. (2013a). Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J.\u00a0Cereb Blood Flow Metab. 33: 1711\u20131715, https:\/\/doi.org\/10.1038\/jcbfm.2013.152.","DOI":"10.1038\/jcbfm.2013.152"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_083","doi-asserted-by":"crossref","unstructured":"Xin, H., Li, Y., Liu, Z., Wang, X., Shang, X., Cui, Y., Zhang, Z.G., and Chopp, M. (2013b). MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells 31: 2737\u20132746, https:\/\/doi.org\/10.1002\/stem.1409.","DOI":"10.1002\/stem.1409"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_084","doi-asserted-by":"crossref","unstructured":"Ye, Y.-C., Chang, Z.-H., Wang, P., Wang, Y.-W., Liang, J., Chen, C., Wang, J.-J., Sun, H.-T., Wang, Y., and Li, X.-H. (2022). Infarct-preconditioning exosomes of umbilical cord mesenchymal stem cells promoted vascular remodeling and neurological recovery after stroke in rats. Stem Cell Res. Ther. 13: 378, https:\/\/doi.org\/10.1186\/s13287-022-03083-9.","DOI":"10.1186\/s13287-022-03083-9"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_085","doi-asserted-by":"crossref","unstructured":"Yoon, E.-J., Choi, Y., Kim, T.M., Choi, E.-K., Kim, Y.-B., and Park, D. (2022). The neuroprotective effects of exosomes derived from TSG101-overexpressing human neural stem cells in a stroke model. Int. J. Mol. Sci. 23: 9532, https:\/\/doi.org\/10.3390\/ijms23179532.","DOI":"10.3390\/ijms23179532"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_086","doi-asserted-by":"crossref","unstructured":"Zhang, Z.G. and Chopp, M. (2016). Exosomes in stroke pathogenesis and therapy. J Clin Investig 126: 1190\u20131197, https:\/\/doi.org\/10.1172\/jci81133.","DOI":"10.1172\/JCI81133"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_087","doi-asserted-by":"crossref","unstructured":"Zhang, H., Wang, Y., Lv, Q., Gao, J., Hu, L., and He, Z. (2018). MicroRNA-21 overexpression promotes the neuroprotective efficacy of mesenchymal stem cells for treatment of intracerebral hemorrhage. Front Neurol. 9: 931, https:\/\/doi.org\/10.3389\/fneur.2018.00931.","DOI":"10.3389\/fneur.2018.00931"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_088","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Zou, X., Zhang, R., Xie, Y., Feng, Z., Li, F., Han, J., Sun, H., Ouyang, Q., Hua, S., et al.. (2021). Human umbilical cord mesenchymal stem cell-derived exosomal miR-146a-5p reduces microglial-mediated neuroinflammation via suppression of the IRAK1\/TRAF6 signaling pathway after ischemic stroke. Aging (Albany NY) 13: 3060\u20133079, https:\/\/doi.org\/10.18632\/aging.202466.","DOI":"10.18632\/aging.202466"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_089","doi-asserted-by":"crossref","unstructured":"Zhao, T., Zhu, T., Xie, L., Li, Y., Xie, R., Xu, F., Tang, H., and Zhu, J. (2022). Neural stem cells therapy for ischemic stroke: progress and challenges. Transl. Stroke Res. 13: 665\u2013675, https:\/\/doi.org\/10.1007\/s12975-022-00984-y.","DOI":"10.1007\/s12975-022-00984-y"},{"key":"2026060415510902395_j_revneuro-2025-0136_ref_090","doi-asserted-by":"crossref","unstructured":"Zhou, J.-f., Xiong, Y., Kang, X., Pan, Z., Zhu, Q., Goldbrunner, R., Stavrinou, L., Lin, S., Hu, W., Zheng, F., et al.. (2022). Application of stem cells and exosomes in the treatment of intracerebral hemorrhage: an update. Stem. Cell Res. Ther. 13: 281, https:\/\/doi.org\/10.1186\/s13287-022-02965-2.","DOI":"10.1186\/s13287-022-02965-2"}],"container-title":["Reviews in the Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2025-0136\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2025-0136\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:52:00Z","timestamp":1780588320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2025-0136\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":90,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2,25]]},"published-print":{"date-parts":[[2026,6,24]]}},"alternative-id":["10.1515\/revneuro-2025-0136"],"URL":"https:\/\/doi.org\/10.1515\/revneuro-2025-0136","relation":{},"ISSN":["0334-1763","2191-0200"],"issn-type":[{"value":"0334-1763","type":"print"},{"value":"2191-0200","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]}}}